This inventor holds 5 USPTO granted patents. Top assignee: Kaneka Corporation. Active years: 2004-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (2004)
- Takasago, JP (2006 - 2012)
- Osaka, JP (2012)
Company Filing History:
Years Active: 2004-2012
Title: Masafumi Fukae: Innovator in Crystallization Methods
Introduction
Masafumi Fukae is a notable inventor based in Takasago, Japan. He has made significant contributions to the field of crystallization methods, particularly in the pharmaceutical industry. With a total of 5 patents to his name, Fukae's work has advanced the understanding and application of crystallization techniques.
Latest Patents
Fukae's latest patents include a method for the crystallization of azetidinonecarboxylic acid. This invention relates to a method for crystallization of (2R)-2-{(3S,4S)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-2-oxoazetidin-4-yl}propionic acid. The method is characterized by mixing a solution containing the compound with a substituted aromatic hydrocarbon solvent and/or a halogenated hydrocarbon solvent. This innovative approach allows for the production of high-purity crystals while maintaining a low level of the 2S isomer. Another significant patent involves an improved crystallization method for intermediates of carbapenem antibiotics, showcasing Fukae's expertise in this critical area of research.
Career Highlights
Fukae is currently employed at Kaneka Corporation, where he continues to develop and refine his crystallization techniques. His work has been instrumental in enhancing the efficiency and effectiveness of pharmaceutical manufacturing processes.
Collaborations
Fukae has collaborated with notable colleagues, including Yoshiro Hiraishi and Keita Nishino. These partnerships have contributed to the advancement of their shared research goals and have fostered innovation within their field.
Conclusion
Masafumi Fukae's contributions to crystallization methods have made a significant impact in the pharmaceutical industry. His innovative approaches and collaborative efforts continue to drive advancements in this essential area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
